Skip to main content
Premium Trial:

Request an Annual Quote

Decode, IBM, Genzyme Molecular Oncology, Luminex, Tm Bioscience


Decode will pair its Clinical Genome Miner tool with IBM hardware and software in a joint marketing and sales agreement, the two companies said Jan. 23. Through the agreement, IBM becomes Decode’s preferred IT provider.

For the next three years the companies will co-market and sell the combined system, and will cooperatively provide consulting, implementation, and integration services.

IBM’s contribution will include its eServer pSeries running AIX and its xSeries running Linux. It will also supply its WebSphere infrastructure software and its DB2 database software. The system will make use of DiscoveryLink data integration methods.

Genzyme Molecular Oncology has won a US patent for its LongSAGE technology, the company said Jan. 27. The patent, No. 6,498,013, covers the gene-expression method that is an expansion of the company’s SAGE technique.

Genzyme Molecular President Gail Maderis said the firm is “now performing the majority of our SAGE analysis” using the new patent. “Combining LongSAGE data with our existing SAGE database has accelerated our identification of novel cancer targets,” she added.

LongSAGE uses a tag from each expressed transcript of about 20-22 base pairs in length, according to Genzyme. These tags in turn help identify each transcript.

Luminex and Tm Bioscience have launched Universal Array, a microsphere-based product designed for genotyping and other DNA-based experiments.

The release of the product, based on Luminex's xMAP technology, also triggers a milestone payment from Luminex to Tm Bioscience and the start of a sales-based royalty stream.

“In contrast to planar DNA microarray platforms, the Universal Array provides a reproducible, high-throughput and cost-effective means of nucleic acid testing,” the partners said.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more